Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced additional follow-up ...

[11] Dyspnea resulting from complications due to an end-stage disease is often treated with a nebulized opioid. Dyspnea can cause great discomfort and worry to patients, and it is difficult to ...

Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and ...

The Maine CDC is excited to announce that we are modernizing our Tuberculosis (TB) reporting system. Currently, inactive TB (also known as Latent TB Infection or LTBI) cases and suspect and confirmed ...